XML 29 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Balance Sheets (USD $)
Mar. 31, 2015
Sep. 30, 2014
Current Assets:    
Cash and cash equivalents $ 347,625us-gaap_CashAndCashEquivalentsAtCarryingValue $ 203us-gaap_CashAndCashEquivalentsAtCarryingValue
Accounts receivable, net of allowance for doubtful 1,704us-gaap_AccountsReceivableNetCurrent   
Due from related parties 7,010us-gaap_DueFromRelatedParties   
Investment in marketable securities 45us-gaap_MarketableSecuritiesEquitySecurities   
Prepaid 7,068us-gaap_PrepaidExpenseAndOtherAssetsCurrent 5,850us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Other assets 4,770us-gaap_OtherAssetsMiscellaneous   
Total Current Assets 368,222us-gaap_AssetsCurrent 6,053us-gaap_AssetsCurrent
Intellectual property, net 3,630us-gaap_IntangibleAssetsNetExcludingGoodwill   
Fixed assets, net 29,162us-gaap_PropertyPlantAndEquipmentOther 5,827us-gaap_PropertyPlantAndEquipmentOther
Total Other Assets 32,792us-gaap_OtherAssets 5,827us-gaap_OtherAssets
TOTAL ASSETS 401,014us-gaap_Assets 11,880us-gaap_Assets
Current Liabilities    
Accounts payable 834,113us-gaap_AccountsPayableCurrent 1,080,619us-gaap_AccountsPayableCurrent
Note payable, related party    20,000us-gaap_OtherNotesPayableCurrent
Accrued expenses 162,959us-gaap_AccruedLiabilitiesCurrent   
Total Current Liabilities 997,072us-gaap_LiabilitiesCurrent 1,100,619us-gaap_LiabilitiesCurrent
Non-Current Liabilities    
Derivative liability 145,543us-gaap_DerivativeLiabilitiesNoncurrent 1,213,336us-gaap_DerivativeLiabilitiesNoncurrent
TOTAL LIABILITIES 1,142,615us-gaap_Liabilities 2,313,955us-gaap_Liabilities
Fuse Science, Inc. Stockholders' Deficit    
Common stock: 800,000,000 authorized; $0.0001 par value 80,000,000 and 233,808 shares issued and outstanding 8,000us-gaap_CommonStockValue 23us-gaap_CommonStockValue
Additional paid-in capital 65,420,511us-gaap_AdditionalPaidInCapitalCommonStock 50,000,750us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated other comprehensive loss (713)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax   
Accumulated deficit (76,539,129)us-gaap_RetainedEarningsAccumulatedDeficit (52,178,004)us-gaap_RetainedEarningsAccumulatedDeficit
Total Fuse Science, Inc. stockholders' deficit (11,103,270)us-gaap_StockholdersEquity (2,175,731)us-gaap_StockholdersEquity
Non-controlling interest 10,361,669us-gaap_MinorityInterest (126,344)us-gaap_MinorityInterest
Total Stockholders' Deficit (741,601)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest (2,302,075)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 401,014us-gaap_LiabilitiesAndStockholdersEquity 11,880us-gaap_LiabilitiesAndStockholdersEquity
Series A Preferred Stock [Member]    
Fuse Science, Inc. Stockholders' Deficit    
Preferred stock, $0.001 par value; authorized 3,500,000 shares; 3,500,000 shares issued and outstanding 1,362us-gaap_PreferredStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesAPreferredStockMember		 1,500us-gaap_PreferredStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesAPreferredStockMember
Series B Preferred Stock [Member]    
Fuse Science, Inc. Stockholders' Deficit    
Preferred stock, $0.001 par value; authorized 3,500,000 shares; 3,500,000 shares issued and outstanding 3,200us-gaap_PreferredStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesBPreferredStockMember		   
Series C Preferred Stock [Member]    
Fuse Science, Inc. Stockholders' Deficit    
Preferred stock, $0.001 par value; authorized 3,500,000 shares; 3,500,000 shares issued and outstanding $ 3,500us-gaap_PreferredStockValue
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesCPreferredStockMember